Now Diagnostics’ Rapid Blood Pregnancy Test Receives Approval in Europe for Over-The-Counter Sales

Now Diagnostics Inc., which is known for our ADEXUSDx® product line in the US, is excited to announce that our over-the-counter (OTC) product line FIRST TO KNOW®, has recently received approval for OTC sales in Europe!

FIRST TO KNOW® is an easy to use, blood-based pregnancy test, that will detect pregnancy much sooner than urine-based pregnancy tests currently available OTC.

Giving women the option to know they’re pregnant sooner, coupled with the Global demand for a more sensitive, lab-accurate at home pregnancy test, made FIRST TO KNOW® the perfect fit for consumers in the European Market.

Read the full article here.

Previous Article Next Article

Check out what is making the news

Find out the latest in diagnostics testing.

NOWDiagnostics Hires Todd Grice as VP of Sales

Todd Simpson

Springdale, AR, October 18, 2023 – NOWDiagnostics (NOWDx) announces Todd Grice as the World-wide Vice President of Sales. Todd is a proven executive sales leader with over 30 years of experience in the diagnostics industry. His extensive knowledge bringing ...

NOWDx and AeenaDx Announce Merger

Todd Simpson

We are pleased to announce the merger of NOWDx and AEENA Dx. The combined entity will directly address healthcare’s expansive need for POC and OTC diagnostics at scale. The combination of NOWDx's “Touch to Test” diagnostic platform enabling blood and saliva...

NOWDiagnostics granted CE Mark for Rapid Syphilis Test

Sophie Hefner

On May 25, 2022, NOWDiagnostics was granted CE Mark for the ADEXUSDx® Syphilis rapid test. This treponemal assay requires only 1 drop of whole blood to perform and yields a laboratory quality result in just 15 minutes. The test has 100% sensitivity for all ...